Clinical Trials Browser

Active not recruiting × spartalizumab × Genitourinary × Clear all

Carcinoma, Renal Cell

NCT03860272 2025-02-06

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

GastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fibrolamellar hepatocellular carcinoma, Carcinoma, Non-Small-Cell Lung, Hemangiosarcoma, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

SPARC-1

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer